ReviewBeilstein journal of nanotechnology2025
Prospects of nanotechnology and natural products for cancer and immunotherapy.
Review in Beilstein journal of nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology is revolutionizing pharmaceutical industry and drug development by providing significant advantages in controlling drug release, enhancing stability, and reducing adverse effects. Concurrently, natural products are being extensively researched for their anticancer and immunomodulatory properties. This patent review aims to analyze publications that integrate nanotechnology with natural products to develop cancer treatments and immunotherapies. In this context, 17 patents were identified through the free online databases of the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO). The review discusses various types of nanotechnology, including nanoparticles, nanocarriers, and nanocapsules, as well as bioactive compounds primarily extracted from plants. Among the most frequently identified natural products were ursolic acid, hyaluronic acid, and catechins. These bioactive compounds have been shown to promote cell cycle arrest, reduce tumor size, and exhibit synergistic effects with other anticancer agents. Consequently, the combination of natural products with nanotechnology holds significant therapeutic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.